Signal active
Organization
Contact Information
Overview
Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of software products radically reduces cost and time to complete research, enabling drastic productivity improvements.
Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.
With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources.
Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era.
About
Cloud Computing, Software, Biotechnology, Open Source, Genetics
2008
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Eagle Genomics headquartered in Europe, operates in the Cloud Computing, Software, Biotechnology, Open Source, Genetics sector. The company focuses on Cloud Computing and has secured $11.3B in funding across 260 round(s). With a team of 11-50 employees, Eagle Genomics is actively contributing to advancements in Cloud Computing. Their latest funding round, Seed Round - Eagle Genomics, raised $1.6M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
13
5
0
$43.5M
Details
4
Eagle Genomics has raised a total of $43.5M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Early Stage Venture | 9.0M | ||
2022 | Early Stage Venture | 19.8M | ||
2013 | Seed | 665.2K | ||
2013 | Seed | 1.6M |
Investors
Eagle Genomics is funded by 49 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Cambridge Angels group | - | FUNDING ROUND - Cambridge Angels group | 1.6M |
Cambridge Capital Group | - | FUNDING ROUND - Cambridge Capital Group | 1.6M |
Eagle Genomics | - | FUNDING ROUND - Eagle Genomics | 1.6M |
Future Planet Capital | - | FUNDING ROUND - Future Planet Capital | 1.6M |
Recent Activity
There is no recent news or activity for this profile.